OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GHAI.PSX56

Ghani Chemical Industries Ltd

Commodity ChemicalsVerified

Ghani Chemical Industries Ltd maintains a debt-to-equity ratio of 0.5, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it can cover short-term obligations but with limited surplus. Free cash flow stands at PKR 576.05 million, supporting operational flexibility and potential reinvestment. Profitability metrics show a return on equity (ROE) of 21.88% and a return on assets (ROA) of 12.39%, both exceeding the typical thresholds for the Commodity Chemicals industry. These figures suggest strong asset utilization and efficient equity deployment, aligning with the company's focus on industrial and medical gases. The company operates through two segments: Industrial Chemicals and Industrial and Medical Gases. While the financial data does not provide segment-specific revenue, the business description indicates a diversified customer base across multiple industries, including healthcare, pharmaceuticals, and oil and gas. This diversification may help mitigate revenue concentration risks. Looking ahead, the company's growth trajectory is supported by a positive outlook for the current fiscal year, with expected revenue growth driven by increased demand in the healthcare and industrial sectors. The capital expenditure of PKR -1.36 billion indicates ongoing investment in infrastructure and operational capacity, which could support future revenue expansion. Risk factors include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's reliance on debt financing and the volatility of the industrial gases market could pose challenges. Recent events and filings have not been disclosed in the provided data, so no specific recent developments can be cited. The company's operations are subject to regulatory and geopolitical factors, particularly in the context of the Pakistan market, which may influence its performance.

30-day price · GHAI.PSX+1.55 (+5.9%)
Low$26.01High$33.00Close$27.75As of15 May, 00:00 UTC
Profile
CompanyGhani Chemical Industries Ltd
TickerGHAI.PSX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Ghani Chemical Industries Ltd is a Pakistan-based company engaged in the manufacturing, sale, and trading of medical and industrial gases and chemicals, serving sectors such as healthcare, pharmaceuticals, and oil and gas.

Classification. Ghani Chemical Industries Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Ghani Chemical Industries Ltd maintains a debt-to-equity ratio of 0.5, indicating a balanced capital structure with moderate leverage. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it can cover short-term obligations but with limited surplus. Free cash flow stands at PKR 576.05 million, supporting operational flexibility and potential reinvestment. Profitability metrics show a return on equity (ROE) of 21.88% and a return on assets (ROA) of 12.39%, both exceeding the typical thresholds for the Commodity Chemicals industry. These figures suggest strong asset utilization and efficient equity deployment, aligning with the company's focus on industrial and medical gases. The company operates through two segments: Industrial Chemicals and Industrial and Medical Gases. While the financial data does not provide segment-specific revenue, the business description indicates a diversified customer base across multiple industries, including healthcare, pharmaceuticals, and oil and gas. This diversification may help mitigate revenue concentration risks. Looking ahead, the company's growth trajectory is supported by a positive outlook for the current fiscal year, with expected revenue growth driven by increased demand in the healthcare and industrial sectors. The capital expenditure of PKR -1.36 billion indicates ongoing investment in infrastructure and operational capacity, which could support future revenue expansion. Risk factors include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. However, the company's reliance on debt financing and the volatility of the industrial gases market could pose challenges. Recent events and filings have not been disclosed in the provided data, so no specific recent developments can be cited. The company's operations are subject to regulatory and geopolitical factors, particularly in the context of the Pakistan market, which may influence its performance.
Key takeaways
  • Ghani Chemical Industries Ltd demonstrates strong profitability with a ROE of 21.88% and ROA of 12.39%.
  • The company maintains a balanced capital structure with a debt-to-equity ratio of 0.5.
  • Free cash flow of PKR 576.05 million supports operational flexibility and reinvestment.
  • The company serves a diversified customer base across multiple industries, reducing revenue concentration risk.
  • Liquidity risk is moderate, with a current ratio of 1.31 and negative net cash after debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$7.44B
Gross profit$3.41B
Operating income$3.09B
Net income$2.01B
R&D
SG&A
D&A
SBC
Operating cash flow$1.55B
CapEx-$1.36B
Free cash flow$576.1M
Total assets$16.24B
Total liabilities$7.04B
Total equity$9.20B
Cash & equivalents$750.4M
Long-term debt$4.63B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.20B
Net cash-$3.88B
Current ratio1.3
Debt/Equity0.5
ROA12.4%
ROE21.9%
Cash conversion77.0%
CapEx/Revenue-18.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricGHAI.PSXActivity
Op margin41.5%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin27.1%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin45.9%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-18.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity50.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:33 UTC#8630c1ba
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:35 UTCJob: 93040238